IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,944,000 | -88.6% | 145,000 | -80.3% | 0.16% | -94.8% |
| Q3 2015 | $25,879,000 | -69.3% | 735,000 | -59.9% | 2.97% | -67.7% |
| Q2 2015 | $84,263,000 | -7.1% | 1,835,000 | -5.2% | 9.20% | +61.0% |
| Q1 2015 | $90,693,000 | +22.9% | 1,935,000 | -17.0% | 5.72% | +10.7% |
| Q4 2014 | $73,814,000 | +33.6% | 2,330,000 | 0.0% | 5.16% | +107.8% |
| Q3 2014 | $55,244,000 | – | 2,330,000 | – | 2.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |